A phase three clinical trial determined that a 3-drug combination improved lung function and reduced symptoms in cystic fibrosis (CF) patients who have a single copy of the most common genetic mutation for the disease.
from Latest Science News -- ScienceDaily https://ift.tt/32bZLGo
via IFTTT
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment